Bosulif (bosutinib) — Medica
Chronic myeloid leukemia (Philadelphia chromosome-positive or BCR::ABL1-positive)
Initial criteria
- Patient has Philadelphia chromosome-positive chronic myeloid leukemia OR BCR::ABL1-positive chronic myeloid leukemia
Approval duration
1 year